4//SEC Filing
Kurata Lance 4
Accession 0001193805-25-001764
CIK 0001768224other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:20 PM ET
Size
5.7 KB
Accession
0001193805-25-001764
Insider Transaction Report
Form 4
Kurata Lance
Chief Legal Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-12-17+54,000→ 54,000 totalExercise: $6.52Exp: 2035-12-17→ Common Stock (54,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
- [F2]The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.
Documents
Issuer
Arcturus Therapeutics Holdings Inc.
CIK 0001768224
Entity typeother
Related Parties
1- filerCIK 0001820961
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:20 PM ET
- Size
- 5.7 KB